MedTrace Logo

HIV Counseling and Testing and Linkage to Care in Uganda

NCT00648232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3415

Last updated 2013-12-12

No results posted yet for this study

Summary

This study will compare the effectiveness of brief versus detailed HIV counseling sessions, paired with referrals to either HIV-specific medical care or usual care, in reducing HIV risk behavior and in increasing treatment adherence in Uganda.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

Voluntary brief HIV counseling and testing

Participants will receive 10 to 15 minutes of pretest counseling on the importance of HIV testing and on available services for people infected with HIV. After pretest counseling, participants will undergo a blood draw for HIV testing. Participants will receive test results and additional counseling 1 hour after the blood sample is drawn.

BEHAVIORAL

Voluntary longer, more detailed HIV counseling and testing

Participants will receive 45 to 60 minutes of pretest counseling on general HIV/AIDS information and testing for HIV. After pretest counseling, participants will undergo a blood draw for HIV testing. Participants will receive test results and additional counseling 1 hour after the blood sample is drawn.

BEHAVIORAL

Enhanced linkage to care

Participants will be provided with more detailed counseling on how to access HIV services, will be introduced to a specific HIV clinic, and will be given a list of other HIV services available in the area. After leaving the hospital, participants will receive reminder telephone calls 1 week before their scheduled visits at the HIV clinics.

BEHAVIORAL

Routine referral to care

Participants will be provided with information on the importance of receiving HIV care and will be given a list of available HIV area services.

Sponsors & Collaborators

Principal Investigators

  • Thomas J. Coates, PhD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00648232 on ClinicalTrials.gov